The analysis of differential diagnosis of benign and malignant thyroid nodules based on ultrasound reports.
Pathological
thyroid
thyroid imaging-reporting and data system (TI-RADS)
ultrasound
Journal
Gland surgery
ISSN: 2227-684X
Titre abrégé: Gland Surg
Pays: China (Republic : 1949- )
ID NLM: 101606638
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
entrez:
11
8
2020
pubmed:
11
8
2020
medline:
11
8
2020
Statut:
ppublish
Résumé
Thyroid cancer is a common endocrine tumor, the incidence of which is increasing each year. Early diagnosis and treatment can effectively prevent thyroid cancer. This article uses Chinese's ultrasound reports to determine the value of early diagnosis. The clinical data center of the First Affiliated Hospital of Nanjing Medical University was screened for patients diagnosed with a thyroid nodule, who had undergone a thyroid function test, ultrasound records and pathological assessment. A total of 811 patients with a total of 1,290 pathologically confirmed nodules (506 benign and 784 malignant) were enrolled. Logistic regression was used to analyze the variables that significantly affected malignant nodules. The sensitivity and specificity of ultrasound thyroid imaging-reporting and data system (TI-RADS) classification results for benign and malignant tumors were calculated. The age of the patients had a very significant difference in the classification of benign and malignant nodules (P<0.001), and the marital status was significantly different (P<0.05). Gender and medical insurance had no significant effect (P>0.05). Thyroglobulin (TG), free thyroxine (FT4), and free triiodothyronine (FT3) had significant effects (P=0.003) on the incidence of malignant nodules in patients, while thyroid-stimulating hormone (TSH) had no significant effect (P>0.05). Ultrasound analysis showed a Youden's index of 78.97%, a positive predictive value of 93.20%, and a negative predicted value of 84.10% at the most excellent classification effect. The sensitivity was 89.0%, the specificity was 89.9%; much greater than the classification model based on the thyroid function test (sensitivity =80.6%, specificity =55.8%). The present study verifies the effectiveness of using TI-RADS classification for diagnosis of benign and malignant thyroid nodules, and explores the use of new analysis methods for clinical data. To reduce dependence on the doctors, ultrasound image data and clinical phenotypic data can be further used to assist clinical decision making.
Sections du résumé
BACKGROUND
BACKGROUND
Thyroid cancer is a common endocrine tumor, the incidence of which is increasing each year. Early diagnosis and treatment can effectively prevent thyroid cancer. This article uses Chinese's ultrasound reports to determine the value of early diagnosis.
METHODS
METHODS
The clinical data center of the First Affiliated Hospital of Nanjing Medical University was screened for patients diagnosed with a thyroid nodule, who had undergone a thyroid function test, ultrasound records and pathological assessment. A total of 811 patients with a total of 1,290 pathologically confirmed nodules (506 benign and 784 malignant) were enrolled. Logistic regression was used to analyze the variables that significantly affected malignant nodules. The sensitivity and specificity of ultrasound thyroid imaging-reporting and data system (TI-RADS) classification results for benign and malignant tumors were calculated.
RESULTS
RESULTS
The age of the patients had a very significant difference in the classification of benign and malignant nodules (P<0.001), and the marital status was significantly different (P<0.05). Gender and medical insurance had no significant effect (P>0.05). Thyroglobulin (TG), free thyroxine (FT4), and free triiodothyronine (FT3) had significant effects (P=0.003) on the incidence of malignant nodules in patients, while thyroid-stimulating hormone (TSH) had no significant effect (P>0.05). Ultrasound analysis showed a Youden's index of 78.97%, a positive predictive value of 93.20%, and a negative predicted value of 84.10% at the most excellent classification effect. The sensitivity was 89.0%, the specificity was 89.9%; much greater than the classification model based on the thyroid function test (sensitivity =80.6%, specificity =55.8%).
CONCLUSIONS
CONCLUSIONS
The present study verifies the effectiveness of using TI-RADS classification for diagnosis of benign and malignant thyroid nodules, and explores the use of new analysis methods for clinical data. To reduce dependence on the doctors, ultrasound image data and clinical phenotypic data can be further used to assist clinical decision making.
Identifiants
pubmed: 32775255
doi: 10.21037/gs.2020.04.03
pii: gs-09-03-653
pmc: PMC7347809
doi:
Types de publication
Journal Article
Langues
eng
Pagination
653-660Informations de copyright
2020 Gland Surgery. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/gs.2020.04.03). The authors have no conflicts of interest to declare.
Références
Indian J Radiol Imaging. 2012 Jan;22(1):63-8
pubmed: 22623819
Genet Mol Res. 2015 Jan 15;14(1):9-20
pubmed: 25729930
Thyroid. 2019 Jun;29(6):858-867
pubmed: 30929637
J Cancer Epidemiol. 2013;2013:965212
pubmed: 23737785
Sci Rep. 2017 Oct 30;7(1):14350
pubmed: 29084994
Endocrine. 2017 Aug;57(2):256-261
pubmed: 27804016
JAMA Oncol. 2016 Aug 1;2(8):1023-9
pubmed: 27078145
Gland Surg. 2018 Oct;7(5):473-486
pubmed: 30505769
J Clin Endocrinol Metab. 2014 Apr;99(4):1253-63
pubmed: 24276450
Eur Rev Med Pharmacol Sci. 2017 Jan;21(2):346-360
pubmed: 28165551
Diagn Cytopathol. 2019 Sep;47(9):853-862
pubmed: 31245935
Int J Clin Pract. 2005 Nov;59(11):1340-4
pubmed: 16236090
Thyroid. 2005 Jul;15(7):708-17
pubmed: 16053388
Can J Surg. 2017 Apr;60(2):134-139
pubmed: 28338469
Horm Metab Res. 2018 Aug;50(8):597-601
pubmed: 30081407
Nat Rev Endocrinol. 2012 May 29;8(7):390-1
pubmed: 22641002
Head Neck. 2019 Jul;41(7):2277-2284
pubmed: 30759328
Thyroid. 2019 Mar;29(3):421-429
pubmed: 30693851
J Clin Endocrinol Metab. 2019 Mar 1;104(3):785-792
pubmed: 30329071
J Med Syst. 2012 Jun;36(3):1271-81
pubmed: 20839035
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Future Oncol. 2017 Jun;13(14):1253-1261
pubmed: 28617107
Horm Metab Res. 2018 Oct;50(10):735-737
pubmed: 30312983